| Issue |
Title |
File |
| Vol 12, No 3 (2025) |
Clonal hematopoiesis of indeterminate potential and malignant neoplasms |
(Rus)
|
|
Shevchenko V.E., Kushnir T.I., Gudkova M.V., Arnotskaya N.E.
|
| Vol 12, No 3 (2025) |
In vitro models of soft tissue sarcomas: basic and clinical aspects |
(Rus)
|
|
Bokova U.A., Tretyakova M.S., Kozlova P.K., Korobeynikova A.A., Menyailo M.E., Gerashchenko T.S., Denisov E.V.
|
| Vol 12, No 3 (2025) |
Multiple aspects of the chemotherapy effect on immune response |
(Rus)
|
|
Fedorenko A.A., Patysheva M.R., Fedorov A.A., Stakheyeva M.N., Cherdyntseva N.V., Gerashchenko T.S.
|
| Vol 12, No 2 (2025) |
Prognostic and predictive molecular biomarkers of colorectal cancer |
(Rus)
|
|
Shakhmatova A.D., Mirlina E.D., Butrovich G.M., Vostriukhina O.A., Verbenko V.N.
|
| Vol 12, No 2 (2025) |
Epstein–Barr virus and mechanisms of molecular carcinogenesis |
(Rus)
|
|
Molchanov A.D., Vasilyeva A.S., Smirnova K.V., Nemtsova M.V.
|
| Vol 12, No 2 (2025) |
Molecular genetic classification of endometrial cancer in the context of personalised medicine |
(Rus)
|
|
Lyubchenko L.N., Mukhtarulina S.V., Meshkova M.A., Sidakova Z.A., Volchenko N.N., Novikova E.G.
|
| Vol 12, No 2 (2025) |
Cytotoxicity mechanisms of passive anti-GD2 immunotherapy in pediatric tumors |
(Rus)
|
|
Melnikov M.E., Kulyova S.A., Kondratiev G.V., Vasilyeva M.M., Savelieva O.E.
|
| Vol 12, No 2 (2025) |
Ferroptosis determinants – potential predictors and therapeutic targets for acute myeloid leukemia |
(Rus)
|
|
Shevchenko V.E., Kushnir T.I., Gudkova M.V., Arnotskaya N.E.
|
| Vol 12, No 1 (2025) |
The balance between deception and adaptation: vasculogenic mimicry as a tumor survival strategy |
(Rus)
|
|
Prosekina E.A., Shapkina V.A., Karpov A.E., Fedorutseva E.Y., Artemyeva A.S.
|
| Vol 12, No 1 (2025) |
Les Liaisons dangereuses: the paradoxical outcomes of the cytotoxic activity of tumor macrophages |
(Rus)
|
|
Kovaleva O.V., Rashidova M.A., Sinyov V.V., Malashenko O.S., Gratchev A.N.
|
| Vol 12, No 1 (2025) |
Signaling cascades are targets for breast cancer therapy in the light of genome – wide sequencing data |
(Rus)
|
|
Gulyaeva L.F., Filipenko M.L., Kushlinskii N.E.
|
| Vol 11, No 4 (2024) |
Mechanistic and epidemiological evidence on the relationship between microbiota, virome and carcinogenesis |
(Rus)
|
|
Yakubovskaya M.G., Fetisov T.I., Solenova L.G., Ryzhova N.I., Lokhonina A.V., Antonova I.A., Belitsky G.A., Kirsanov K.I., Aginova V.V.
|
| Vol 11, No 4 (2024) |
Immunotherapy of malignant gliomas: a modern view on the problem |
(Rus)
|
|
Pichugin А.А., Kovyazina R.R., Trondin А., Alekseev А.G., Kopnin P.B., Gessel T.V., Boichuk S.V.
|
| Vol 11, No 4 (2024) |
The role of methionine cycle disruption in the initiation and progression of malignant tumors |
(Rus)
|
|
Ruksha T.G., Kurbat M.N., Palkina N.V., Kutsenko V.A.
|
| Vol 11, No 3 (2024) |
Germline and somatic alterations in NBN and their putative impact on the pathogenesis of malignant neoplasms |
(Rus)
|
|
Krivtsova O.M., Ozerova D.D., Lazarevich N.L.
|
| Vol 11, No 3 (2024) |
Immunological tolerance in breast cancer: some reasons for development |
(Rus)
|
|
Kayukova E.V., Bolotov E.S.
|
| Vol 11, No 3 (2024) |
Molecular genetic and biochemical profiles of malignant neoplasms during pregnancy |
(Rus)
|
|
Chernyshova A.L., Chernyakov A.A., Truschuk Y.M., Yunusova N.V., Sevostyanova N.V., Arkhipova Y.I., Dil O.S., Chernyshova A.E.
|
| Vol 11, No 3 (2024) |
Two-faced Janus: on the 150th anniversary of the discovery of DDT |
(Rus)
|
|
Morozova O.V., Bukina A.Y., Popova V.G., Khairieva G.I., Sagitova G.R., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I., Maksimova V.P.
|
| Vol 11, No 2 (2024) |
The most common forms of cancer and oncogenic papillomaviruses |
(Rus)
|
|
Volgareva G.M.
|
| Vol 11, No 2 (2024) |
Molecular classifications of gastric cancer and their clinical potential |
(Rus)
|
|
Nemtsova M.V., Molchanov A.D., Kuznetsova E.B., Bure I.V.
|
| Vol 11, No 2 (2024) |
A modern view of the role of genetic factors in the etiopathogenesis of breast cancer |
(Rus)
|
|
Pavlova N.V., Dyomin S.S., Churnosov M.I., Ponomarenko I.V.
|
| Vol 11, No 2 (2024) |
Modern approaches in suicidal gene therapy of malignant neoplasms |
(Rus)
|
|
Dudkina E.V., Ulyanova V.V., Ilinskaya O.N.
|
| Vol 11, No 2 (2024) |
Sodium-dependent phosphate transporter NaPi2b as a candidate for targeted therapy: features of structure, function, and expression |
(Rus)
|
|
Kiyamova R.G., Vlasenkova R.A., Bulatova L.F.
|
| Vol 11, No 2 (2024) |
Potential to use of viral reverse transcriptase inhibitors in oncology |
(Rus)
|
|
Vlasova O.A., Antonova I.A., Magomedova K.M., Usolkina M.A., Kirsanov K.I., Belitsky G.A., Valiev T.T., Yakubovskaya M.G.
|
| Vol 10, No 3 (2023) |
Sexual dimorphism in cancer |
(Rus)
|
|
Belitsky G.A., Kirsanov K.I., Lesovaya E.A., Maksimova V.P., Krivosheeva L.V., Yakubovskaya M.G.
|
| Vol 10, No 3 (2023) |
The role of mycoplasmas as an infectious agent in carcinogenesis |
(Rus)
|
|
Galyamina M.A., Pobeguts O.V., Gorbachev A.Y.
|
| Vol 10, No 3 (2023) |
Modern understanding of risk factors and mechanisms of breast cancer development |
(Rus)
|
|
Pavlova N.P., Dyomin S.S., Churnosov M.I., Ponomarenko I.V.
|
| Vol 10, No 3 (2023) |
Current approaches to systemic treatment of BRCA-associated triple-negative breast cancer |
(Rus)
|
|
Enaldieva D.A., Krivorotko P.V., Imyanitov E.N., Zhiltsova E.K., Donskikh R.V., Shaikhelislamova L.F., Gigolaeva L.P., Semiglazov V.F.
|
| Vol 10, No 1 (2023) |
Targeting of the SWI/SNF chromatin remodeling complex in cancer therapy |
(Rus)
|
|
Nemtsova M.V., Bure I.V.
|
| Vol 10, No 1 (2023) |
Breast cancer association with oncogenic papillomaviruses: arguments pro and con |
(Rus)
|
|
Volgareva G.M.
|
| Vol 9, No 4 (2022) |
Mechanisms of the carcinogenicity of nanomaterials |
(Rus)
|
|
Belitsky G.A., Kirsanov K.I., Lesovaya E.A., Yakubovskaya M.G.
|
| Vol 9, No 4 (2022) |
Aberrations of DNA methylation in cancer |
(Rus)
|
|
Maksimova V.P., Usalka O.G., Makus Y.V., Popova V.G., Trapeznikova E.S., Khayrieva G.I., Sagitova G.R., Zhidkova E.M., Prus A.Y., Yakubovskaya M.G., Kirsanov K.I.
|
| Vol 9, No 3 (2022) |
Significance of tumor-associated macrophages in bladder cancer development |
(Rus)
|
|
Pavlov V.N., Urmantsev M.F., Korelov Y.A., Bakeev M.R.
|
| Vol 9, No 3 (2022) |
Prospects for the use of statins in the treatment of neurofibromatosis type 1 |
(Rus)
|
|
Mustafin R.N.
|
| Vol 9, No 2 (2022) |
Breast cancer association with oncogenic papillomaviruses: papillomaviral DNA detection in breast cancer cells |
(Rus)
|
|
Volgareva G.M.
|
| Vol 9, No 2 (2022) |
Milk exosomes as delivery agents for therapy of cancer diseases |
(Rus)
|
|
Sedykh S.E., Timofeeva A.M., Kuleshova A.E., Nevinskiy G.A.
|
| Vol 8, No 4 (2021) |
The mechanism of development of post-traumatic gliomas |
(Rus)
|
|
Gareev I.F., Filippov Y.G., Beylerli O.A., Sufianov A.A., Tyurin A.V., Mukhametov U.F., Yang G., Beylerli A.T.
|
| Vol 8, No 4 (2021) |
The role of retroelements in the development of hereditary tumor syndromes |
(Rus)
|
|
Mustafin R.N., Khusnutdinova E.K.
|
| Vol 8, No 4 (2021) |
Efficiency in different immunotherapy of cancer: literature review |
(Rus)
|
|
Gaptulbarova K.A., Tsyganov M.M., Ibragimova M.K., Pevzner A.M., Spirina L.V., Litviakov N.V.
|
| Vol 8, No 4 (2021) |
Immunology and prospects of immunotherapy against malignant gliomas: humoral immunity |
(Rus)
|
|
Kulyova S.A., Borokshinova K.M., Druy A.E.
|
| Vol 8, No 3 (2021) |
The role of mutations in NF1 gene in sporadic carcinogenesis |
(Rus)
|
|
Mustafin R.N.
|
| Vol 8, No 3 (2021) |
Circulating predictive markers of immune checkpoint inhibitors in non-small cell lung cancer |
(Rus)
|
|
Musaelyan A.A., Akopov A.L., Lapin S.V., Nazarov V.D., Fillipov D.I., Emanuel V.L., Orlov S.V.
|
| Vol 8, No 3 (2021) |
LYN kinase and estrogen receptor ERα: involvement in carcinogenesis and potential therapeutic target for tumors |
(Rus)
|
|
Tikhonova V.V., Finashutina Y.P., Kesaeva L.A.
|
| Vol 8, No 3 (2021) |
Glioblastoma: a molecular genetic portrait and modern therapeutic strategies for drug treatment |
(Rus)
|
|
Guens G.P., Sanikovich V.D., Mileyko V.A., Lebedeva A.A.
|
| Vol 8, No 2 (2021) |
Modern concepts of the molecular pathogenesis of thyroid cancer |
(Rus)
|
|
Mikhailova A.A., Shestakov A.V., Chubakova K.A., Kolokolova E.V., Eliseev V.Y., Kostyaeva M.Y., Akperov E.G., Pilipenko V.E., Saprina T.V., Mukhamedov M.R., Choinzonov E.L.
|
| Vol 8, No 2 (2021) |
Prognostic and predictive significance of osteopontin in malignant neoplasms |
(Rus)
|
|
Zubareva E.Y., Senchukova M.A.
|
| Vol 8, No 2 (2021) |
Role of nitric oxide and endothelial NO synthase in carcinogenesis |
(Rus)
|
|
Deryagina V.P., Rizhova N.I., Savluchinskaya L.A., Kirsanov K.I.
|
| Vol 8, No 1 (2021) |
Еstrogen receptor α (ESR1) and SRC family kinase (LYN) gene's mutations associated with ovarian cancer endocrine therapy resistance |
(Rus)
|
|
Shestakova E.A.
|
| Vol 7, No 4 (2020) |
The prospect of using liquid biopsy in diagnosis and treatment strategy in patients with carcinomas of unknown primary |
(Rus)
|
|
Kononenko I.B., Filippova M.G., Snegovoy A.V., Gutorov S.L.
|
| Vol 7, No 4 (2020) |
Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis |
(Rus)
|
|
Mikhaylova I.N., Treshalina N.M., Shubina I.Z., Manina I.V., Kiselevsky M.V., Lukashev A.N.
|
| Vol 7, No 3 (2020) |
The role of extracellular vesicles in the diagnosis of glioblastoma progression |
(Rus)
|
|
Ryabova A.I., Novikov V.A., Yunusova N.V., Ponomareva A.A., Spirina L.V., Gribova O.V.
|
| Vol 7, No 3 (2020) |
Role of microRNAs in neuroendocrine neoplasms of the stomach |
(Rus)
|
|
Peregorodiev I.N., Vinokurova S.V., Bohyan V.Y., Delektorskaya V.V., Malikhova O.A., Gorbunova V.A., Sakibov B.I., Elkin D.S., Stilidi I.S.
|
| Vol 7, No 3 (2020) |
Molecular portrait of stomach cancer associated with the Epstein–Barr virus |
(Rus)
|
|
Ignatova E.O., Seryak D.A., Fedyanin M.Y., Tryakin A.A., Pokataev I.A., Menshikova S.F., Vakhabova Y.V., Karbyshev M.S., Smirnova K.V., Tulyandin S.A.
|
| Vol 7, No 2 (2020) |
The interplay of autophagy and epithelial-to-mesenchymal transition in cancer progression |
(Rus)
|
|
Ryabaya O.O., Prokofieva A.A.
|
| Vol 7, No 2 (2020) |
The modern views of the clinical, morphological and molecular biological predictors of breast cancer sensitivity to chemotherapy |
(Rus)
|
|
Zubareva E.Y., Sen’chukova M.A.
|
| Vol 7, No 1 (2020) |
The therapeutic potential of curcumin for the treatment of glioblastoma multiforme |
(Rus)
|
|
Kushnir T.I., Arnotskaya N.E., Kudryavtsev I.A., Shevchenko V.E.
|
| Vol 7, No 1 (2020) |
Current approaches to assessment of the impact of the environmental contamination on cancer risk |
(Rus)
|
|
Solenova L.G.
|
| Vol 6, No 4 (2019) |
Determination of chemoresistance of ovarian cancer cells in vitro |
(Rus)
|
|
Kuzin K.A., Fetisov T.I., Knyazev R.I., Fomina L.Y., Meheda L.V., Lesovaya E.A., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I.
|
| Vol 6, No 3 (2019) |
Modern approaches for the screening of epigenetically active xenobiotics |
(Rus)
|
|
Maksimova V.P., Bugaeva P.E., Zhidkova E.M., Usalka O.G., Lesovaya E.A., Belitsky G.A., Yakubovskaya M.G., Kirsanov K.I.
|
| Vol 6, No 2 (2019) |
Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance |
(Rus)
|
|
Villert A.B., Kolomiets L.A., Yunusova N.V.
|
| Vol 6, No 2 (2019) |
Clinical and genetic aspects of differential diagnostics of hereditary non-polyposis colorectal cancer |
(Rus)
|
|
Semyanikhina A.V., Rasulov A.O., Lyubchenko L.N.
|
| Vol 6, No 2 (2019) |
Promises of targeted therapy for low grade gliomas in children |
(Rus)
|
|
Valiakhmetova E.F., Yasko L.A., Papusha L.I., Druy A.E., Karachunsky A.I.
|
| Vol 6, No 1 (2019) |
Autoantibodies against tumor-associated antigens as one class of serological markers |
(Rus)
|
|
Marshutina N.V., Sergeeva N.S., Alentov I.I., Kaprin A.D.
|
| Vol 6, No 1 (2019) |
Modulation of the formation of active forms of nitrogen by ingredients of plant products in the inhibition of carcinogenesis |
(Rus)
|
|
Deryagina V.P., Reutov V.P.
|
| Vol 6, No 1 (2019) |
Molecular genetic aspects of intrahepatic cholangiocarcinoma: literature review |
(Rus)
|
|
Gurmikov B.N., Kovalenko Y.A., Vishnevsky V.A., Chzhao A.V.
|
| Vol 5, No 4 (2018) |
Wnt-signaling pathway in pathogenesis of glioblastoma multiforme |
(Rus)
|
|
Vasilets Y.D., Arnotskaya N.E., Kudryavtsev I.A., Shevchenko V.E.
|
| Vol 5, No 4 (2018) |
Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsy |
(Rus)
|
|
Kustova I.F., Makarova A.S., Lazarevich N.L.
|
| Vol 5, No 4 (2018) |
Tumor associated macrophages: current research and perspectives of clinical use |
(Rus)
|
|
Gratchev A.N., Samoilova D.V., Rashidova M.A., Petrenko A.A., Kovaleva O.V.
|
| Vol 5, No 4 (2018) |
Producing and prospects for the use of bispecific antibodies for the treatment of cancer |
(Rus)
|
|
Sedykh S.E., Nevinsky G.A.
|
| Vol 5, No 4 (2018) |
Influence of DNA-binding compounds with cancer preventive activity on the mechanisms of gene expression regulation |
(Rus)
|
|
Kirsanov K.I., Vlasova O.A., Fetisov T.I., Zenkov R.G., Lesovaya E.A., Belitsky G.A., Gurova K., Yakubovskaya M.G.
|
| Vol 5, No 4 (2018) |
HIFα as a target for different oncoproteins during carcinogenesis |
(Rus)
|
|
Kobliakov V.A.
|
| Vol 5, No 4 (2018) |
Role of TRIM16 in cancers development |
(Rus)
|
|
Spirina L.V., Kondakova I.V., Tarasenko N.V.
|
| Vol 5, No 4 (2018) |
Small GTPase Rab3B: biological properties and possible role in carcinogenesis |
(Rus)
|
|
Budko A.A., Khesina P.A., Diakov L.M., Lazarevich N.L.
|
| Vol 5, No 4 (2018) |
The role of integrins αv in the pathogenesis of oral squamous cell carcinoma |
(Rus)
|
|
Tuguzbaeva G.M., Pavlov V.N.
|
| Vol 5, No 3 (2018) |
Clinical, morphological, and molecular genetic predictors of metastatic lesions in the regional lymph nodes in breast cancer |
(Rus)
|
|
Dergunova Y.A., Podionov V.V., Bozhenko V.K., Kometova V.V., Dardyk M.V.
|
| Vol 5, No 3 (2018) |
The mechanisms of acquired resistance to anti-EGFR drugs in non-small cell lung cancer not associated with T790m mutation and their significance in clinical practice |
(Rus)
|
|
Karabina E.V., Lubchenko L.N., Davydov M.M.
|
| Vol 5, No 3 (2018) |
Healthcare workers: occupational carcinogenic factors and cancer risk |
(Rus)
|
|
Solenova L.G., Nekrasova L.A.
|
| Vol 5, No 2 (2018) |
A STUDY OF THE ROLE OF MICRORNA IN PITUITARY ADENOMA |
(Rus)
|
|
Gareev I.F., Beylerli O.A.
|
| Vol 5, No 2 (2018) |
IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT |
(Rus)
|
|
Ilnitskaya A.S., Danilova A.B., Baldueva I.A.
|
| Vol 5, No 1 (2018) |
Proteoglycans in normal physiology and carcinogenesis |
(Rus)
|
|
Suhovskih A.V., Grigorieva E.V.
|
| Vol 5, No 1 (2018) |
Asynchronous replication in oncological patients |
(Rus)
|
|
Mikhailova G.F., Tsepenko V.V., Shkavrova T.G., Goloub E.V.
|
| Vol 4, No 4 (2017) |
MOLECULAR GENETIC ASPECTS OF HEPATOCELLULAR CARCINOMA PATHOGENESIS AND CURRENT OPTIONS OF DRUG THERAPY |
(Rus)
|
|
Makarova A.S.
|
| Vol 4, No 3 (2017) |
Chemotherapy: some potential risks under antineoplastic drugs handling |
(Rus)
|
|
Solenova L.G., Yakubovskaya M.G.
|
| Vol 4, No 3 (2017) |
Metabolic aspects of adoptive immunotherapy of tumors |
(Rus)
|
|
Kazanskiy D.B., Silaeva Y.Y., Kalinina A.A., Zamkova M.A., Khromykh L.M., Persiyantseva N.A., Dzholokhava L.K.
|
| Vol 4, No 3 (2017) |
MicroRNA-155-5p in pathogenesis of cancer |
(Rus)
|
|
Zborovskaya I.B., Komel’kov A.V.
|
| Vol 4, No 3 (2017) |
The role of epigenetic factors in the pathogenesis of neurofibromatosis type 1 |
(Rus)
|
|
Mustafin R.N., Khusnutdinova E.K.
|
| Vol 4, No 3 (2017) |
Secreted protein YB-1 and its prognostic significance |
(Rus)
|
|
Stavrovskaya A.A., Moiseeva N.I., Guens G.P., Rybalkina E.Y.
|
| Vol 4, No 3 (2017) |
Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer |
(Rus)
|
|
Lyubchenko L.N., Filippova M.G., Shendrikova T.A., Zhukova L.G., Mekhtieva N.I., Krokhina O.V., Portnoy S.M.
|
| Vol 4, No 2 (2017) |
IQGAP scaffold proteins are the multifunctional regulators of cellular signaling and malignant transformation |
(Rus)
|
|
Skovorodnikova P.A., Chesnokov M.S., Budko A.A., Kustova I.F., Lazarevich N.L.
|
| Vol 4, No 2 (2017) |
Neuroendocrine tumors of the lung: the current classification and pathology diagnosis algorithm |
(Rus)
|
|
Delektorskaya V.V.
|
| Vol 4, No 2 (2017) |
Prevention of malignant neoplasms |
(Rus)
|
|
Zaridze D.G., Maksimovich D.M.
|
| Vol 4, No 2 (2017) |
Cancer as a result of genetic mosaicism |
(Rus)
|
|
Likhtensteyn A.V.
|
| Vol 4, No 1 (2017) |
Actin isoforms and neoplastic transformation |
(Rus)
|
|
Dugina V.B., Shagieva G.S., Khromova N.V., Kopnin P.B.
|
| Vol 4, No 1 (2017) |
The thymidine kinase-1 as a potential tumor marker: structure, function, activity in normal and malignant tissues |
(Rus)
|
|
Sergeeva N.S., Parilova N.K., Marshutina N.V., Meysner I.S.
|
| Vol 4, No 1 (2017) |
Heterogeneity and clonal evolution of colorectal cancer |
(Rus)
|
|
Fedyanin M.Y., Elsnukaeva H.H., Tjulandin S.A.
|
| Vol 4, No 1 (2017) |
Clinical and morphological characteristics of neuroendocrine tumors: clinical experience |
(Rus)
|
|
Raskin G.A., Ivanova A.K., Orlova R.V.
|
| Vol 3, No 3 (2016) |
Second primary malignancies of cancer patients: treatment-related carcinogenesis |
(Rus)
|
|
Belitskiy G.A., Lesovaya E.A., Kirsanov K.I., Yakubovskaya M.G.
|
| Vol 3, No 3 (2016) |
Morphological classification of digestive neuroendocrine neoplasms: the current concepts and controversies |
(Rus)
|
|
Delektorskaya V.V.
|
| Vol 3, No 3 (2016) |
The phenomenon of RNA interference in oncology: advances, problems and perspectives |
(Rus)
|
|
Andreeva O.E., Krasil’nikov M.A.
|
| Vol 3, No 3 (2016) |
Microdomain forming proteins in oncogenesis |
(Rus)
|
|
Zborovskaya I.B., Galetskiy S.A., Komel’kov A.V.
|
| 1 - 100 of 131 Items |
1 2 > >>
|
